Noemi Rotllan obtained her B.Sc and MS in Biology in 1996 from the University of Barcelona, and earned her Ph.D. degree in 2003. She completed her first postdoctoral trainee position in Dr. Edward Fisher's laboratory at NYU with a Fulbright fellowship. Following that, she completed her second postdoctoral trainee position in Dr. Carlos Fernández Hernando's laboratory at NYU and Yale University, where she was an Associate Research Scientist. She studied the role of miRNAs in regulating lipoprotein metabolism and the progression of atherosclerosis. Dr. Rotllan was also a recipient of the Scientific Development Grant award from the AHA. In 2019 she moved back to Barcelona in order to start her own laboratory, as she had received the prestigious Ramon y Cajal fellowship award. Her research interests are focused mainly on the role of new microRNAs in hiperhomocysteinemia-related atherosclerosis and the use of innovative therapeutic approaches for targeting miRNAs in vivo.